Alginos Oral Suspension for esophagitis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Feb 2024: Trial started, NCT06958445
  2. 6 May 2025: Trial registered, NCT06958445

The trials

NCT06958445: Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy

State
Under way
Phase
Phase 2
People
90 planned
Started
15 Feb 2024
Primary completion
Dec 2026
Arms
Esophagitis prevention
Results
None posted
  1. 15 Feb 2024: Trial started
  2. 6 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.